People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Biotechnology, Biotech / Pharma, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cerapedics Inc | — | Biotechnology | Series B | $99.1M | $492.3M | 2009 |
| Carbon Biosciences, Inc. | — | Biotech / Pharma | Series B | $38.0M | $744.8M | 2022 |
| Brainstorm Cell Therapeutics Inc. | — | Biotechnology | Series A | $12.3M | $379.6M | 2012 |
| Novalere FP, Inc. | — | Pharmaceuticals | Series A | $6.5M | $201.3M | 2013 |
Chen Schor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chen Schor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Cohen | 1 | 38 |
| David Steinberg | 1 | 14 |
| Jonathan Silverstein | 1 | 10 |
| Chau Khuong | 1 | 9 |
| Geeta Vemuri | 1 | 7 |
| Noah Kroloff | 1 | 6 |
| Tyrell Rivers | 1 | 6 |
| Derek Yoon | 1 | 4 |
| Glen Kashuba | 1 | 3 |
| Antony Koblish | 1 | 3 |
| Robert Hadfield | 1 | 2 |
| Irit Arbel | 1 | 2 |
| Robert Shorr | 1 | 2 |
| Valerie Friedman | 1 | 2 |
| Ken Abramowitz | 1 | 2 |
| Leonard Habas | 1 | 1 |
| Andrew J Tofe | 1 | 1 |
| Samuel S. Wu | 1 | 1 |
| Chau J. Khuong | 1 | 1 |
| Chen J. Schor | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.